This topic contains a solution. Click here to go to the answer

Author Question: A client who takes oral hypoglycemics for type 2 diabetes mellitus is diagnosed with a severe ... (Read 15 times)

viki

  • Hero Member
  • *****
  • Posts: 525
A client who takes oral hypoglycemics for type 2 diabetes mellitus is diagnosed with a severe infection and is ordered to receive levofloxacin (Levaquin).
 
  Based on the interaction of the medications, the highest priority nursing intervention is to frequently assess:
  a. complete blood count.
  b. BUN and creatinine levels.
  c. liver enzymes.
  d. serum blood glucose level.

Question 2

The client will be prescribed Achromycin. The nurse anticipates that this medication will be given:
 
  a. with each meal.
  b. with extra water.
  c. on an empty stomach.
  d. one half-hour after meals.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Bison

  • Sr. Member
  • ****
  • Posts: 342
Answer to Question 1

ANS: D
Interaction of these two medications may lead to hypoglycemia.

Answer to Question 2

ANS: C
Tetracycline is best absorbed on an empty stomach.




viki

  • Member
  • Posts: 525
Reply 2 on: Jul 23, 2018
YES! Correct, THANKS for helping me on my review


adf223

  • Member
  • Posts: 304
Reply 3 on: Yesterday
Excellent

 

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

Approximately one in four people diagnosed with diabetes will develop foot problems. Of these, about one-third will require lower extremity amputation.

Did you know?

In 2006, a generic antinausea drug named ondansetron was approved. It is used to stop nausea and vomiting associated with surgery, chemotherapy, and radiation therapy.

Did you know?

In most cases, kidneys can recover from almost complete loss of function, such as in acute kidney (renal) failure.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library